b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">30214813</PMID>\n        <DateCompleted>\n            <Year>2019</Year>\n            <Month>02</Month>\n            <Day>04</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2019</Year>\n            <Month>02</Month>\n            <Day>15</Day>\n        </DateRevised>\n        <Article PubModel="Electronic-eCollection">\n            <Journal>\n                <ISSN IssnType="Electronic">2052-1707</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>6</Volume>\n                    <Issue>5</Issue>\n                    <PubDate>\n                        <Year>2018</Year>\n                        <Month>10</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Pharmacology research &amp; perspectives</Title>\n                <ISOAbbreviation>Pharmacol Res Perspect</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Elevated 4\xce\xb2-hydroxycholesterol/cholesterol ratio in anorexia nervosa patients.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>e00430</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1002/prp2.430</ELocationID>\n            <Abstract>\n                <AbstractText>Recent studies have shown that the cytochrome P450 (CYP) 3A phenotype marker 4\xce\xb2-hydroxycholesterol/cholesterol (4\xce\xb2OHC/C) ratio is negatively correlated with body weight in healthy volunteers, and that obese patients have lower 4\xce\xb2OHC levels than healthy controls. However, 4\xce\xb2OHC/C ratio in underweight patients has yet to be reported. The aim of this study was to examine potential differences in CYP3A activity between underweight patients with anorexia nervosa and normal-weight volunteers by measuring plasma 4\xce\xb2OHC/C ratio. Furthermore, we wished to describe any association between body mass index (BMI) and 4\xce\xb2OHC/C ratio in underweight patients. A total of 20 underweight patients and 16 normal-weight volunteers were included in the study, all females. Underweight patients had a median 4\xce\xb2OHC/C ratio (molar ratio\xc2\xa0\xc3\x97\xc2\xa010<sup>-5</sup>) of 2.52 (range, 0.90-11.3) compared to 1.29 (0.56-2.09) in normal-weight subjects (Mann-Whitney <i>P\xc2\xa0</i>=\xc2\xa00.0005). 4\xce\xb2OHC/C ratio was negatively correlated with BMI in underweight patients (<i>r\xc2\xa0</i>=\xc2\xa0-0.56, <i>P\xc2\xa0</i>=\xc2\xa00.011), and in the whole study population (<i>r\xc2\xa0</i>=\xc2\xa0-0.67, <i>P\xc2\xa0</i>&lt;\xc2\xa00.0001). This suggests that the negative correlation between 4\xce\xb2OHC/C and BMI, which has previously been reported between 4\xce\xb2OHC/C and body weight in healthy volunteers, extends to underweight patients. The findings indicate that CYP3A activity increases with decreasing BMI, resulting in higher CYP3A activity in underweight patients compared to normal-weight subjects. The potential clinical relevance of this needs to be studied further by comparing pharmacokinetics of drugs subjected to CYP3A-mediated metabolism in underweight vs. normal-weight individuals.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Hole</LastName>\n                    <ForeName>Kristine</ForeName>\n                    <Initials>K</Initials>\n                    <Identifier Source="ORCID">0000-0001-7300-5329</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>Center for Psychopharmacology Diakonhjemmet Hospital Oslo Norway.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Heiberg</LastName>\n                    <ForeName>Petra L</ForeName>\n                    <Initials>PL</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Center for Psychopharmacology Diakonhjemmet Hospital Oslo Norway.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Gjestad</LastName>\n                    <ForeName>Caroline</ForeName>\n                    <Initials>C</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Center for Psychopharmacology Diakonhjemmet Hospital Oslo Norway.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Mehus</LastName>\n                    <ForeName>Lise L</ForeName>\n                    <Initials>LL</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Medicinal Biochemistry Diakonhjemmet Hospital Oslo Norway.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>R\xc3\xb8</LastName>\n                    <ForeName>\xc3\x98yvind</ForeName>\n                    <Initials>\xc3\x98</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Regional Department for Eating Disorders Division of Mental Health and Addiction Oslo University Hospital Oslo Norway.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Mental Health and Addiction Institute of Clinical Medicine University of Oslo Oslo Norway.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Molden</LastName>\n                    <ForeName>Espen</ForeName>\n                    <Initials>E</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Center for Psychopharmacology Diakonhjemmet Hospital Oslo Norway.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Pharmaceutical Biosciences School of Pharmacy University of Oslo Oslo Norway.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2018</Year>\n                <Month>09</Month>\n                <Day>11</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>United States</Country>\n            <MedlineTA>Pharmacol Res Perspect</MedlineTA>\n            <NlmUniqueID>101626369</NlmUniqueID>\n            <ISSNLinking>2052-1707</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D006888">Hydroxycholesterols</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>17320-10-4</RegistryNumber>\n                <NameOfSubstance UI="C099828">cholest-5-ene-3,4-diol</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>97C5T2UQ7J</RegistryNumber>\n                <NameOfSubstance UI="D002784">Cholesterol</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>EC 1.14.14.1</RegistryNumber>\n                <NameOfSubstance UI="C104464">CYP3A protein, human</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>EC 1.14.14.1</RegistryNumber>\n                <NameOfSubstance UI="D051544">Cytochrome P-450 CYP3A</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000856" MajorTopicYN="N">Anorexia Nervosa</DescriptorName>\n                <QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>\n                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName>\n                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D015992" MajorTopicYN="N">Body Mass Index</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D002784" MajorTopicYN="N">Cholesterol</DescriptorName>\n                <QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>\n                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D051544" MajorTopicYN="N">Cytochrome P-450 CYP3A</DescriptorName>\n                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D064368" MajorTopicYN="N">Healthy Volunteers</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006888" MajorTopicYN="N">Hydroxycholesterols</DescriptorName>\n                <QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>\n                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="Y">4\xce\xb2\xe2\x80\x90hydroxycholesterol</Keyword>\n            <Keyword MajorTopicYN="Y">BMI</Keyword>\n            <Keyword MajorTopicYN="Y">CYP3A</Keyword>\n            <Keyword MajorTopicYN="Y">anorexia nervosa</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2018</Year>\n                <Month>08</Month>\n                <Day>02</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2018</Year>\n                <Month>08</Month>\n                <Day>21</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2018</Year>\n                <Month>9</Month>\n                <Day>15</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2018</Year>\n                <Month>9</Month>\n                <Day>15</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2019</Year>\n                <Month>2</Month>\n                <Day>5</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>epublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">30214813</ArticleId>\n            <ArticleId IdType="doi">10.1002/prp2.430</ArticleId>\n            <ArticleId IdType="pii">PRP2430</ArticleId>\n            <ArticleId IdType="pmc">PMC6134200</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Reference>\n                <Citation>J Biol Chem. 2002 Aug 30;277(35):31534-40</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12077124</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Life Sci. 2014 Nov 18;118(1):27-33</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25445438</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>AAPS J. 2018 Apr 9;20(3):61</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29858698</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Basic Clin Pharmacol Toxicol. 2016 Apr;118(4):284-91</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26399557</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Gastroenterol Hepatol. 1996 Jan;11(1):33-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">8672739</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Eur J Clin Pharmacol. 2011 May;67(5):493-506</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21140139</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Pharmacol Ther. 2013 Mar;93(3):275-82</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23361102</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Pharmacol Ther. 2013 Apr;138(1):103-41</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23333322</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>AAPS J. 2016 Sep;18(5):1056-66</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27350147</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Br J Clin Pharmacol. 2017 Jul;83(7):1457-1465</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28146606</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Steroids. 2015 Jul;99(Pt B):287-92</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25896943</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Br J Clin Pharmacol. 2011 Feb;71(2):183-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21219398</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Sci Rep. 2016 Jan 22;6:19694</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26795945</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Ann Clin Biochem. 2012 Mar;49(Pt 2):132-43</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22349551</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Br J Clin Pharmacol. 2016 Feb;81(2):269-76</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26574235</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Eur J Clin Pharmacol. 2012 Oct;68(10):1411-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22441315</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Drug Metab Dispos. 2014 Jan;42(1):105-10</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24135442</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>N Engl J Med. 1977 Jan 27;296(4):190-3</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">831089</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Endocrinol (Oxf). 2003 Jan;58(1):22-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12519408</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Pharmacol Ther. 2009 Aug;86(2):147-53</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19458613</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Br J Clin Pharmacol. 2009 Jan;67(1):38-43</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19006545</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Pharmacogenet Genomics. 2008 Mar;18(3):201-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18300941</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Clin Pharmacol Ther. 1999 Jan;37(1):8-19</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">10027478</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Drug Metab Dispos. 2013 Apr;41(4):704-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23386704</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Basic Clin Pharmacol Toxicol. 2016 Jun;118(6):499-502</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26617265</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Eur J Clin Pharmacol. 2017 Mar;73(3):317-324</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27975131</ArticleId>\n                </ArticleIdList>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'